Clyburn Frank
- SEC CIK
- 0001763963
No open-market purchases or sales filed in the past year.
Current role at each company
- RVMD Revolution Medicines, Inc.Directoras of Jun 23, 2026
- KLRA Kailera Therapeutics, Inc.Directoras of Apr 20, 2026
- COR Cencora, Inc.Directoras of Mar 9, 2026
- IFF International Flavors & Fragrances IncChief Executive Officeras of Mar 5, 2024
- MRK Merck & Co., Inc.EVP & Pres ? Human Healthas of Nov 4, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Clyburn Frank as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRK Merck & Co., Inc.
EVP & Pres ? Human Health1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Clyburn FrankEVP & Pres ? Human Health | SSale | −39.8K | $87.87 | −$3.49M | −29.1%97.1K after |